Hepatitis C Treatment: News & Analysis
- CROI's Hep C Treatment News (May/June 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
On TheBodyPRO.com
- Victrelis "Not Recommended" With Some HIV Meds (May/June 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
 U.S.: Do Not Mix Merck Hepatitis Pill With HIV Drugs (April 30, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Updated Information on Drug Interactions Between Victrelis (Boceprevir) and Certain Boosted HIV Protease Inhibitor Drugs (April 26, 2012)
From U.S. Food and Drug Administration
- Boceprevir a Useful Option for Patients Who Did Not Respond to Earlier Course of Hepatitis C Therapy (April 23, 2012)
From aidsmap.com
- Telaprevir and Boceprevir Show High Rate of Serious Side Effects in Hepatitis C Patients With Urgent Need of Treatment (April 20, 2012)
From aidsmap.com
- Gilead, Bristol Put Profits Ahead of Best Care for Hep C Patients (April 19, 2012)
One of the most effective new therapies in development for hepatitis C -- daclatasvir plus GS-7977 -- may never see the light of day because the developers seem unable to work together.
From The Street
- No Relevant Interactions Between Telaprevir and Two Newest Nonnucleosides Rilpivirine and Etravirine (April 17, 2012)
From National AIDS Treatment Advocacy Project
- EASL Starts Tomorrow -- Get Ready for the HCV Treatment Deluge (April 17, 2012)
From Journal Watch
- British Columbia Expands Coverage Under PharmaCare Plan for New Drug for Hepatitis C (March 30, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
 Incivek Triple Therapy Looks Simply Great in HIV/HCV-Coinfected Patients: A Blog Entry by Barbara McGovern, M.D. (March 28, 2012)
From TheBody.com
- Victrelis in the Spotlight for HIV/HCV-Coinfected Patients: A Blog Entry by Barbara McGovern, M.D. (March 26, 2012)
From TheBody.com
- Merck's Hepatitis C Drug Wins UK Cost Endorsement (March 12, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Vertex, Merck Hepatitis Drugs Work in HIV Patients (March 8, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
- Managing Side Effects From New Hepatitis C Drugs (March 2012)
To read PDF, click here.
In Treatment Update, from Canadian AIDS Treatment Information Exchange
 Interactions Between Certain HIV or Hepatitis C Drugs and Cholesterol-Lowering Statin Drugs Can Increase the Risk of Muscle Injury (March 1, 2012)
From U.S. Food and Drug Administration
- Making Sense of the Drug Interaction Warning for HIV/HCV-Coinfected Patients Taking Victrelis: A Blog Entry by Barbara McGovern, M.D. (February 28, 2012)
From TheBody.com
- Vitrelis (Boceprevir) in HIV/HCV-Coinfected Patients: A Look at Recent Research -- A Blog Entry by Barbara McGovern, M.D. (February 28, 2012)
From TheBody.com
- United Kingdom: Hepatitis C Breakthroughs "Wasted" (February 15, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Merck Says Hepatitis Pill Hampers HIV Drugs (February 13, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- FDA Drug Safety Communication: Important Drug Interactions Between Victrelis (Boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs (February 8, 2012)
From U.S. Food and Drug Administration
|
Advertisement
|
Email
Glossary
